CymitQuimica logo
Tyrosine Kinase/Adaptors

Tyrosine Kinase/Adaptors

Tyrosine kinase and adaptor inhibitors are compounds that target tyrosine kinases and their associated adaptor proteins, which play pivotal roles in cell signaling, growth, and differentiation. These inhibitors are essential tools in cancer research, as many tyrosine kinases are involved in the signaling pathways that drive tumor growth and metastasis. By inhibiting tyrosine kinases, these compounds can block critical signaling cascades, offering potential therapeutic strategies for various cancers and other diseases involving abnormal cell signaling. At CymitQuimica, we provide a comprehensive range of high-quality tyrosine kinase and adaptor inhibitors to support your research in oncology, molecular biology, and targeted therapy development.

Subcategories of "Tyrosine Kinase/Adaptors"

Show 13 more subcategories

Found 1170 products of "Tyrosine Kinase/Adaptors"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • c-Kit-IN-8

    CAS:
    C-Kit-IN-8 (Compound 53) acts as an inhibitor of c-Kit kinase, hampering uKIT kinase activity with an IC50 greater than 1 μM. Additionally, it inhibits the proliferation of both wild-type and mutant GIST430 and BaF3 cancer cells, exhibiting an IC50 greater than 0.1 μM.
    Formula:C24H26FN5O4
    Color and Shape:Solid
    Molecular weight:467.49

    Ref: TM-T200947

    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire
  • ITK inhibitor 2

    CAS:
    ITK inhibitor 2 (compound 4) is a potent and selective ITK inhibitor with an IC50= 2 nM.
    Formula:C25H33N5O2
    Purity:99.67%
    Color and Shape:Solid
    Molecular weight:435.56

    Ref: TM-T11690

    1mg
    57.00€
    5mg
    120.00€
    10mg
    188.00€
    25mg
    432.00€
    50mg
    747.00€
    100mg
    1,017.00€
    200mg
    1,359.00€
  • c-Fms-IN-15

    CAS:
    c-Fms-IN-15 (compound 8g) is a potent inhibitor of FMS kinase, with an IC50 of 563 nM.
    Formula:C29H28F3N7O2
    Molecular weight:563.57

    Ref: TM-T210059

    10mg
    To inquire
    50mg
    To inquire
  • EGFR-IN-125

    CAS:
    <p>EGFR-IN-125 (example 37) is a potent EGFR inhibitor with IC50 values of &lt;0.3 nM for EGFR(d746-750/T790M/C797S), 0.52 nM for EGFR(L858R/T790M/C797S), 0.5 nM for EGFR(d746-750/C797S), 0.69 nM for EGFR(L858R/C797S), and 0.92 nM for EGFR (wild type).</p>
    Formula:C30H26N8O
    Color and Shape:Solid
    Molecular weight:514.58

    Ref: TM-T204450

    10mg
    To inquire
    50mg
    To inquire
  • HER2-IN-12


    HER2-IN-12 is an HER2 inhibitor with an IC50 value of 121 nM and can be used to study cancers such as breast cancer.
    Formula:C17H18BrN5O2S
    Color and Shape:Solid
    Molecular weight:436.33

    Ref: TM-T62487

    25mg
    1,444.00€
    50mg
    1,882.00€
    100mg
    2,375.00€
  • EGFR-IN-130


    EGFR-IN-130 (compound 14b) is an EGFR inhibitor and an inducer of apoptosis (apoptoosis). It effectively kills HeLa cancer cells by inducing apoptosis.
    Formula:C27H25N3O6S
    Color and Shape:Solid
    Molecular weight:519.57

    Ref: TM-T201686

    10mg
    To inquire
    50mg
    To inquire
  • TrkA-IN-8

    CAS:
    TrkA-IN-8 (Compound 2) is a TrkA inhibitor with a Kd value of 3.3 µM. RTKs-IN-1 demonstrates a concentration-dependent inhibitory effect on the proliferation of lung cancer cell lines and holds potential for research in non-small cell lung cancer.
    Formula:C20H16N4
    Color and Shape:Solid
    Molecular weight:312.368

    Ref: TM-T205511

    10mg
    To inquire
    50mg
    To inquire
  • IGF-1R inhibitor-4

    CAS:
    <p>IGF-1Rinhibitor-4 (compound 22) is a potent inhibitor of IGF-1R, demonstrating an inhibition rate of 63% at a concentration of 10 μM. This compound plays a significant role in cancer research.</p>
    Formula:C13H15ClN4O
    Color and Shape:Solid
    Molecular weight:278.737

    Ref: TM-T204141

    10mg
    To inquire
    50mg
    To inquire
  • TrkA-IN-7

    CAS:
    <p>TrkA-IN-7 (Compound 4) is an inhibitor of tropomyosin receptor kinase A (TrkA), with a Kd value of 40 μM.</p>
    Formula:C16H13N3O3
    Color and Shape:Solid
    Molecular weight:295.293

    Ref: TM-T204489

    10mg
    To inquire
    50mg
    To inquire
  • Andamertinib

    CAS:
    Andamertinib is an EGFR inhibitor with antitumor activity.
    Formula:C31H36N8O3
    Color and Shape:Solid
    Molecular weight:568.669

    Ref: TM-T206579

    10mg
    To inquire
    50mg
    To inquire
  • EGFR/BRAF-IN-1


    EGFR/BRAF-IN-1 inhibits EGFR/BRAF (BRAFV600E IC50: 45 nM, GI50: 35 nM) and has antioxidant properties.
    Formula:C26H28ClN3O4
    Color and Shape:Solid
    Molecular weight:481.97

    Ref: TM-T63189

    25mg
    1,444.00€
    50mg
    1,882.00€
    100mg
    2,375.00€
  • EGFR-IN-126

    CAS:
    EGFR-IN-126 (compound 9d) is an effective inhibitor of EGFR L858R/T790M/C797S, displaying an IC50 value of 0.005 μM. It exhibits antitumor activity both in vivo and in vitro.
    Formula:C28H28BrFN4O3
    Color and Shape:Solid
    Molecular weight:567.45

    Ref: TM-T200496

    25mg
    1,559.00€
    50mg
    2,110.00€
    100mg
    2,603.00€
  • DYRKs-IN-1

    CAS:
    <p>DYRKs-IN-1 has antitumor activity.</p>
    Formula:C30H30ClN7O4
    Purity:98%
    Color and Shape:Solid
    Molecular weight:588.06

    Ref: TM-T11132

    25mg
    2,300.00€
    50mg
    3,022.00€
    100mg
    4,085.00€
  • EGFR-IN-38

    CAS:
    EGFR-IN-38: low-toxic acrylamide-derived EGFR inhibitor, targets NSCLC, patented for research on EGFR mutation-related diseases.
    Formula:C25H24ClN7O2
    Color and Shape:Solid
    Molecular weight:489.96

    Ref: TM-T63283

    25mg
    1,444.00€
    50mg
    1,882.00€
    100mg
    2,375.00€
  • EGFR-IN-139

    CAS:
    EGFR-IN-139 (compound PD 18) is an EGFR inhibitor with IC50 values of 12.88 nM (wild type), 10.84 nM (L858R/T790M), and 42.68 nM (L858R/T790M/C797S). It demonstrates significant anticancer activity against the A549 and H1975 cancer cell lines, which express high levels of EGFR. EGFR-IN-139 exhibits strong selectivity for cancer cells and can be utilized in research on non-small cell lung cancer (NSCLC).
    Formula:C27H25ClN2O4
    Color and Shape:Solid
    Molecular weight:476.951

    Ref: TM-T204772

    10mg
    To inquire
    50mg
    To inquire
  • EGFR/HER2/DHFR-IN-1


    Potent EGFR/HER2/DHFR inhibitor for MCF-7 breast cancer; IC50: 0.153/0.108/0.291 μM; arrests G1/S phase, triggers apoptosis.
    Formula:C14H11BrN4O2S
    Color and Shape:Solid
    Molecular weight:379.23

    Ref: TM-T61596

    25mg
    1,444.00€
    50mg
    1,882.00€
    100mg
    2,375.00€
  • EGFR-IN-35

    CAS:
    EGFR-IN-35, an acrylamide-based EGFR inhibitor, shows promise for EGFR mutation-related cancers like NSCLC.
    Formula:C25H24ClN7O2
    Color and Shape:Solid
    Molecular weight:489.96

    Ref: TM-T63282

    25mg
    1,444.00€
    50mg
    1,882.00€
    100mg
    2,375.00€
  • EGFR-IN-17


    EGFR-IN-17: potent, selective EGFR inhibitor, IC50 of 0.2 nM, overcomes C797S drug resistance.
    Formula:C27H31ClN7O3P
    Color and Shape:Solid
    Molecular weight:568.01

    Ref: TM-T64020

    100mg
    1,179.00€
    200mg
    1,669.00€
  • AMG-25

    CAS:
    AMG-25 (c-Kit-IN-5-1) is a c-Kit inhibitor that inhibits c-Kit, KDR, p38, Lck, and Src, and can be used for the study of mast cell-associated fibrotic diseases.
    Formula:C23H17N5O2
    Purity:98.16%
    Color and Shape:Solid
    Molecular weight:395.41

    Ref: TM-T22256

    2mg
    475.00€
  • PET-cGMP

    CAS:
    <p>PET-cGMP is an analogue of cyclic guanosine monophosphate and functions as a potent, selective agonist for PKGI. It exhibits an EC50 of 3.8 nM for PKGIβ and 193 nM for PKGII.</p>
    Formula:C18H16N5O7P
    Color and Shape:Solid
    Molecular weight:445.323

    Ref: TM-T204785

    10mg
    To inquire
    50mg
    To inquire